Jane Street
BNTC icon

Jane Street’s Benitec Biopharma BNTC Stock Holding History

Jane Street’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,425
Closed -$167K – 11624
2025
Q4 		$167K Buy
+12,425
New +$172K ﹤0.01% 9862
2023
Q1 		– Sell
-1,616
Closed -$4.67K – 9058
2022
Q4 		$4.67K Buy
+1,616
New +$5.47K ﹤0.01% 8872

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Jane Street's BNTC Position: Q1 2026 in Review

Jane Street sold out of Benitec Biopharma (BNTC) in Q1 2026, closing a stake of 12,425 shares — an estimated $167K sold.

Jane Street first reported a position in BNTC in Q4 2022 and held it in 2 quarters. The position peaked at $167K in Q4 2025. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Jane Street reported no remaining Benitec Biopharma position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 12,425 Benitec Biopharma shares in Q1 2026, an estimated $167K.
  • Jane Street first reported a position in Benitec Biopharma in Q4 2022 and held it in 2 quarters.
  • Jane Street's Benitec Biopharma position peaked at $167K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.